LAURUS LABS LIMITED

{
    "company_profile": "Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers an integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. It operates through four divisions: Generics API, Generics FDF, CDMO custom synthesis (Laurus Synthesis), and Biotechnology (Laurus Bio). The Generics API is a third-party API supplier for antiretrovirals. The Generic FDF business focuses on oral solid formulations. Laurus Synthesis provides drug development and manufacturing services to global pharma, crop science, animal health, and others. Laurus Bio offers comprehensive services from clone and strain engineering to production, supporting clients across the microbial precision fermentation spectrum. Its solutions cater for sectors, such as regenerative medicine, vaccines, cultured meat, and others.",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 111034.16,
        "unit": "crore",
        "formatted": "111,034.16 Cr"
    },
    "sector_market_cap_usd": {
        "value": 12.34,
        "unit": "billion",
        "formatted": "$12.34B"
    }
}